COVID-19: Johnson & Johnson vaccine could be linked to rare blood clots, EU medicines regulator says

The European Medicines Agency says it has found a possible link between the Johnson & Johnson COVID vaccine and very rare cases of unusual blood clots.

But the EMA also said the "overall benefit-risk remains positive".